Determinants of male health: The interaction of biological and social factors

Asian Journal of Andrology

Volumn 12, Issue 3, 2010, Pages 291-297

  De Kretser, David M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Genetics; Health policy; Impotence; Infertility

Indexed keywords

ADULTHOOD; ANDROGEN RELEASE; CARDIOVASCULAR FUNCTION; CONCEPTION; DEVELOPMENTAL STAGE; ERECTILE DYSFUNCTION; GENOME; HEALTH; HEALTH CARE POLICY; HUMAN; MALE; MALE GENITAL SYSTEM DISEASE; MALE HEALTH; NERVOUS SYSTEM FUNCTION; REVIEW; SOCIAL ASPECT; TESTIS;

ANDROGENS; ATTITUDE TO HEALTH; ERECTILE DYSFUNCTION; GENETIC PREDISPOSITION TO DISEASE; GENOME; HEALTH POLICY; HEALTH STATUS; HUMANS; INFERTILITY, MALE; LONGEVITY; MALE; MEN'S HEALTH; SOCIAL ENVIRONMENT; TESTOSTERONE;

EID: 77952283121     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.15     Document Type: Review

References (48)

1. AIHW. www.aihw.gov. au
2. Marmot M. Social determinants of health inequalities. Lancet 2005;365:1099-104.
3. Ostlin P, Eckermann E, Mishar US, Nkowane M, Wallstam E. Gender and health promotion: a multisectoral policy approach. Health Prom Int 2007;21:25-35.
4. Macdonald JJ. Shifting paradigms: a social-determinants approach to solving problems in men's health policy and practice. Med J Aust 2006;185:456-8.
5. Schofield T, Connell RW, Walker L, Wood JF, Butland DL. Understanding men's health and illness: a gender-relations approach to policy, research and practice. J Am Coll Health 2000;48:247-56.
6. Smith GD, Hart C, Watt G, Hole D, Hawthorne V. Individual social class, area-based deprivation, cardiovascular risk factors and mortality: the Renfrew and Paisley Study. J Epidemiol Community Health 1998;52:399-405.
7. Denton M, Walters V. Gender differences in structural and behavioural determinants of health: an analysis of the social production of health. Soc Sci Med 1999;48:1221-35.
8. Denton M, Prus S, Walters V. Gender differences in health: a Canadian study of the psychosocial, structural and behavioural determinants of health. Soc Sci Med 2004;58:2585-600.
9. Joffe M. Infertility and environmental pollutants. Br Med Bull 2003;68:47-70.
10. De Falco T, Capel B. Gonad morphogenesis in vertebrates: divergent means to a convergent end. Ann Rev Cell Biol 2009;25:457-82.
11. Dewing P, Shi T, Horvath S, Vilain E. Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation. Brain Res Mol Brain Res 2003;118:82-90.
12. Arnold Ap, Xu J, Grisham W, Chen X, Kim Y, et al. Minireview: sex chromosomes and brain sexual differentiation. Endocrinology 2004;145:1057-62.
13. Goldman-Johnson DR, Stanley EG, de Kretser DM, Morrison JR. Evidence that androgens regulate early developmental events, prior to sexual differentiation. Endocrinology 2007;149:5-14.
14. Skuse DH, James RH, Bishop DV, Coppin B, Dalton P, et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 1997;387:705-8.
15. Davies W, Isles A, Smith R, Karunadasa D, Burrmann D, et al. Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice. Nat Genet 2005;37:625-9.
16. Davies W, Isles DW, Burgoyne PS, Wilkinson LS. X-linked imprinting effects on brain and behaviour. Bioessays 2006;28:35-44.
17. Itti E, Gaw Gonzalo IT, Pawlikowska-Haddal A, Boone KB, Mlikotic A, et al. The structural brain correlates of cognitive deficits in adults with Klinefelter's syndrome. J Clin Endocrinol Metab 2006;91:1423-7.
18. Ross JL, Roeltgen DP, Stefanatos G, Benecke R, Zeger MP, et al. Cognitive and motor development during childhood in boys with Klinefelter syndrome. Am J Med Genet A 2008;15, 146 A: 708-19.
19. Bojesen A, Juul S, Gravholt V. Prenatal and post-natal prevalence of Klinefelter's syndrome: a national registry study. J Clin Endocrinol Metab 2003;88:622-6.
20. May PA, Gossage JP, Kalberg WO, Robinson LK, Buckley D, et al. Prevalence and epidemiological characteristics of FSAD from various research methods with an emphasis on recent in-school studies. Dev Disabl Res Rev 2009;15:176-92.
21. Mocarelli P, Gerthoux PM, Ferrarri E, Patterson JG, Kies-zak SM, et al. Paternal concentrations of dioxin and sex ratios of offspring. Lancet 2000;355:858-63.
22. Mandal PK. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol B 2005;175:221-30.
23. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male infertility. Science 2005;308:1391-2.
24. Anway MD, Rekow SS, Skinner MK. Transgenerational epigenetic programming of the embryonic testis transcrip-tome. Genomics 2008;91:30-40.
25. Barker DJ. Fetal origins of cardiovascular disease. Ann Med 1999; Suppl 1:3-6.
26. Eriksson JG, Osmond C, Kajantie E, Forsen TJ, Barker DJ. Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia 2006;49:2853-8.
27. Barker DJ. The origins of the developmental origins theory. J Intern Med 2007;261:412-17.
28. Young LE. Imprinting of genes and the Barker hypothesis. Twin Res 2001;4:307-7.
29. Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, et al. Men in Australia, Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle aged and older Australian men. Lancet 2005;366:218-24.
30. UK Government Offce for Science: Tackling obesities: future choices. Project Report DIUS/Pub8601/2K/10/07/NP. http:\\www.dius.gov. uk
31. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, et al. Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 1995;16:271-321.
32. John Radcliffe Hospital Cryptorchidism Study Group. Cryp-torchidism: a prospective study of 7500 consecutive male births, 1984-1988. Arch Dis Child 1992;67:892-9.
33. Muller J, Skakkebaek NE. Cryptochidism. Curr Ther Endo-crinol Metab 1997;363-6.
34. Cram D, Lynch M, O'Bryan MK, Salvado C, McLachlan R, et al. Genetic screening of infertile men. Reprod Fertil Dev 2004;16:573-80.
35. de Kretser DM. Is spermatogenic damage associated with Leydig cell dysfunction? Editorial. J Clin Endocrinol Metab 2004;89:5158-160.
36. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, et al. Mortality results from a randomized prostate-cancer mortality screening trial. N Engl J Med 2009;360:1310-9.
37. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Gatto S, et al. Screening and prostate cancer mortality in a randomized European study. New Engl J Med 2009;360:1320-8.
38. Holden CA, Jolley DJ, McLachlan RI, Pitts M, Cumming R, et al. Men in Australia Telephone Survey (MATeS): predictors of men's help-seeking behaviour for reproductive health disorders. Med J Aust 2006;185:418-22.
39. Thompson I, Tangen C, Goodman P, Probstfield JL, Moin-pour CM, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294:2996-3002.
40. Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, et al. A population-based longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clinic Proc 2009;84:108-13.
41. Adams M. PhD Thesis. Queensland University of Technology, 2007.
42. Baker HW, Burger HG, de Kretser DM, Hudson B, O'Connor S, et al. Changes in the pituitary-testicular system with age. Clin Endocrinol 1976;5:349-72.
43. Tenover JL. Male hormone replacement therapy including "an-dropause". Endocrinol Metab Clin North Am 1998;27:969-87.
44. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98.
45. Vermeulen A, Kaufman JM, Deslypere JP, Thomas G. Attenuated luteinising hormone [LH] pulse amplitude but normal LH pulse frequency, and its relationship to plasma androgens in hypogonadism of obese men. J Clin Endocri-nol Metab 1993;76:1140-6.
46. Kapoor D, Goodwin E, Channer K, Jones T. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogo-nadal men with type 2 diabetes. Eur J Endocrinol 2006;154:899-906.
47. Meier C, Nguyen TV, Handelsman DJ, Schindler C, Kushnir MM, et al. Endogenous sex hormones and incident fractures in older men. The Dubbo osteoporosis epidemiology study. Arch Int Med 2008;168:47-54.
48. Lee DM, O'Neill TW, Pye SR, Silman AJ, Finn JD, et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 2009;32:11-24.